查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1726264

全球乳癌診斷市場：市場規模、佔有率、趨勢分析（按類型、產品、應用、最終用途和地區）、細分市場預測（2025-2030 年）

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Platform-based, Instrument-based), By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

乳癌診斷市場的成長與趨勢：

根據 Grand View Research Inc. 的一項新研究，到 2030 年全球乳癌診斷市場規模預計將達到 84.7 億美元。

預計從 2025 年到 2030 年，市場複合年成長率將達到 7.64%。這一成長主要是由於老齡人口不斷增加，他們面臨更多的乳癌風險以及乳癌的早期發現，同時人們對乳癌的認知也不斷提高。

3D乳房X光攝影和數位乳房斷層合成技術的推出，比 2D乳房X光攝影具有更高的準確度，從而支持了市場的成長。這項先進技術比2D乳房乳房X光攝影多檢測出 40.0% 的癌症，從而減少患者回訪。預計快速的技術進步是未來幾年推動市場發展的主要因素。

公司正在採取策略利用其資源開發新產品並加強其供應鏈。 2019 年 11 月，Exact Sciences Corporation 宣布收購 Genomic Health，增加了產品系列，預計有助於加強公司的市場地位和服務產品。 2021 年 1 月，Hologic Inc. 宣布已同意以約 2.3 億美國收購 Biotheranostics。 Biotheranostics 是一家針對乳癌和轉移性癌症的商業階段分子診斷提供者。

隨著乳癌預測和伴隨診斷測試的不斷增加，預計市場將會成長。該領域最近推出的產品包括 Myriad Genetics 的 BRACAnalysis CDx，該產品於 2018 年獲得 FDA核准作為乳癌伴隨診斷。 2019 年 5 月，QIAGEN 推出了 therascreen PIK3CA RGQ PCR 試劑盒，作為諾華專有 PIQRAY 的伴隨診斷，以根據切片檢查和液體切片檢查指導治療決策。

2019 年 1 月，FUJIFILM Holdings公司宣布其 ASPIRE Cristalle乳房X光攝影系統將推出斷層合成切片檢查選項。該技術有望透過提供增強的 3D 影像和數位乳房 X 光檢查來幫助醫生比以往更有效地檢測乳癌。

然而，這些成像方式有其自身的風險因素。這些包括使用大量螢光或鋇顯影劑，以及在成像和內視鏡檢查的情況下暴露於輻射，這可能導致多種副作用，包括噁心和腹瀉。 CT、MRI 和 X 光的使用以及 PET 中使用放射性示蹤劑注射所帶來的電離輻射暴露風險可能會限制此類篩檢方法的採用。因此，診斷成像的副作用等因素對該市場的公司構成了挑戰。

乳癌診斷市場：概述

  • 預計診斷成像將在 2024 年佔據最大佔有率的收入，其中血液學檢測預計將以最快的速度成長。
  • 從產品角度來看，由於美國、加拿大和英國等已開發國家政府訂定強制 45 歲以上女性接受收益佔有率等舉措，乳癌檢測和篩檢整體增加，預計 2024 年基於設備的產品部門將佔據最大的收入美國。
  • 預計基於平台的產品領域將在預測期內呈現最快的成長。這些測試主要用於評估女性化療和標靶治療的有效性。
  • 根據應用，診斷和預測部分預計將在 2024 年佔據市場主導地位，而由於合作的不斷增加以及診斷技術進步的努力，預測部分預計將在預測期內呈現最快的複合年成長率。
  • 由於住院人數增加和乳癌負擔增加，醫院和診所部門預計將實現 6.92% 的穩定成長率。
  • 由於 NGS 和 PCR 等基於平台的測試的興起，預計醫療實驗室和診斷中心部門在預測期內將呈現最快的複合年成長率。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 商業環境分析
    • PESTEL分析
    • 波特五力分析
  • COVID-19影響分析

第4章 業務類型分析

  • 乳癌診斷市場：按類型分類的趨勢分析（2024 年和 2030 年）
  • 影像學診斷
    • 診斷影像市場（2018-2030）
  • 切片檢查
    • 切片檢查市場（2018-2030）
  • 基因組檢測
    • 基因組檢測市場（2018-2030）
  • 血液檢查
    • 血液檢測市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第5章 產品業務分析

  • 乳癌診斷市場：產品特定變化分析（2024 年和 2030 年）
  • 平台化產品
    • 平台型產品市場（2018-2030）
  • 基於設備的產品
    • 設備型產品市場（2018-2030）

第6章 依應用程式進行的業務分析

  • 乳癌診斷市場：應用趨勢分析（2024 年和 2030 年）
  • 篩檢
    • 篩檢市場（2018-2030）
  • 診斷和預測
    • 診斷與預測市場（2018-2030）
  • 預後
    • 預測市場（2018-2030）
  • 研究
    • 研究市場（2018-2030）

第7章 按最終用途分類的業務分析

  • 乳癌診斷市場：最終用途趨勢分析（2024-2030）
  • 醫院和診所
    • 醫院和診所市場（2018-2030）
  • 醫學實驗室/診斷中心
    • 醫學實驗室和診斷中心市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第8章區域業務分析

  • 市場概況：按地區
  • 北美洲
    • 北美乳癌診斷市場（2018-2030）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲乳癌診斷市場（2018-2030）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區乳癌診斷市場（2018-2030）
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲乳癌診斷市場（2018-2030）
    • 主要國家趨勢
    • 法律規範
    • 競爭場景
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲乳癌診斷市場（2018-2030）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 公司分類
  • 戰略地圖
    • 收購
    • 商業合作
    • 推出新平台
    • 其他
  • 公司簡介/上市公司
    • Hologic Inc.
    • Genomic Health（Exact Sciences Corporation）
    • BD
    • Danaher
    • Koninklijke Philips NV
    • QIAGEN
    • Thermo Fisher Scientific Inc
    • Myriad Genetics
    • Argon Medical Devices, Inc.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-3-68038-694-3

Breast Cancer Diagnostics Market Growth & Trends:

The global breast cancer diagnostics market size is expected to reach USD 8.47 billion by 2030, according to a new study by Grand View Research Inc. The market is expected to expand at a CAGR of 7.64% from 2025 to 2030. The growth is largely attributable to the increasing geriatric population exposed to the risk of breast cancer and early detection coupled with increasing awareness about breast cancer.

The introduction of 3D mammography or digital breast tomosynthesis, which is more accurate than 2D mammography, supports market growth. This advanced technology can detect 40.0% more cancers than 2D mammograms and reduce patient recalls. Rapid technological advancements are a major factor expected to drive the market over the coming years.

Companies are adopting strategies that allow them to use their resources to aid in the development of new products, as well as enhance their supply chain. In November 2019, Exact Sciences Corporation announced the acquisition of Genomic Health, which was expected to help enhance the company's market position and offerings by acquiring its product portfolio. In January 2021, Hologic Inc. announced that it has agreed to acquire Biotheranostics for approximately US$ 230 million. Biotheranostics is a commercial-stage molecular diagnostics provider for breast and metastatic cancers.

The increasing launch of predictive and companion diagnostic tests for breast cancer is expected to boost the market growth. Recent launches in the segment include BRACAnalysis CDx by Myriad Genetics, which received FDA approval in 2018 as breast cancer companion diagnostics. In May 2019, QIAGEN introduced therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for Novartis proprietary PIQRAY in guiding treatment decisions from tissue and liquid biopsy.

In January 2019, the Fujifilm Holdings Corporation introduced its Tomosynthesis Biopsy option for ASPIRE Cristalle mammography system. This technique was expected to enable physicians to detect breast cancers more efficiently compared to others by providing an enhanced 3D image and a digital mammogram.

However, there are specific risk factors associated with these imaging procedures. They involve administering high doses of fluorescent and barium contrast agents, as well as radiation exposure in the case of imaging and endoscopic procedures, which can cause several adverse effects such as nausea or diarrhea. The risks of ionizing radiation exposure associated with the use of CT, MRI, and X-rays, as well as the use of radioactive tracer injections in PET can limit the adoption of such screening procedures. Therefore, factors such as adverse effects of imaging act as a challenge for the companies in this market.

Breast Cancer Diagnostics Market Report Highlights:

  • The imaging segment held the largest revenue share in 2024 and the blood tests segment is expected to grow at the fastest rate.
  • By product, the instrument-based products segment accounted for the largest revenue share in 2024 due to government initiatives such as mandatory screening in developed countries such as the U.S., Canada, and the U.K. for women above 45 years of age, increasing the overall testing and screening of breast cancer.
  • The platform-based products segment is expected to witness the fastest growth over the forecast period. These tests are mostly used for assessing the efficacy of chemotherapy and targeted therapy in women.
  • By application, the diagnostic and predictive segment dominated the market in 2024 and the prognostic segment is expected to witness the fastest CAGR over the forecast period due to increasing collaborations and efforts for advancements in diagnostics.
  • The hospitals and clinics segment is expected to demonstrate a steady growth rate of 6.92% due to the rising number of hospitalizations and increasing burden of breast cancer.
  • The medical labs and diagnostics centers segment is expected to witness the fastest CAGR over the forecast period due to an increase in platform-based testing such as NGS, and PCR.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Product Snapshot
  • 2.3. Application and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Breast Cancer Diagnostics Market: Type Movement Analysis, 2024 & 2030
  • 4.2. Imaging
    • 4.2.1. Imaging Market, 2018 - 2030 (USD Million)
  • 4.3. Biopsy
    • 4.3.1. Biopsy Market, 2018 - 2030 (USD Million)
  • 4.4. Genomic Tests
    • 4.4.1. Genomic Tests Market, 2018 - 2030 (USD Million)
  • 4.5. Blood Tests
    • 4.5.1. Blood Tests Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Breast Cancer Diagnostics Market: Product Movement Analysis, 2024 & 2030
  • 5.2. Platform-based products
    • 5.2.1. Platform-based Products Market, 2018 - 2030 (USD Million)
  • 5.3. Instrument-based products
    • 5.3.1. Instrument-based Products Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Breast Cancer Diagnostics Market: Application Movement Analysis, 2024 & 2030
  • 6.2. Screening
    • 6.2.1. Screening Market, 2018 - 2030 (USD Million)
  • 6.3. Diagnostic & Predictive
    • 6.3.1. Diagnostic & Predictive Market, 2018 - 2030 (USD Million)
  • 6.4. Prognostic
    • 6.4.1. Prognostic Market, 2018 - 2030 (USD Million)
  • 6.5. Research
    • 6.5.1. Research Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Breast Cancer Diagnostics Market: End Use Movement Analysis, 2024 & 2030
  • 7.2. Hospitals & Clinics
    • 7.2.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.3. Medical labs & Diagnostics Centers
    • 7.3.1. Medical labs & Diagnostics Centers Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.5.2. Key Country Dynamics
    • 8.5.3. Regulatory Framework
    • 8.5.4. Competitive Scenario
    • 8.5.5. Brazil
      • 8.5.5.1. Brazil Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.5.5.2. Key Country Dynamics
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Competitive Scenario
    • 8.5.6. Argentina
      • 8.5.6.1. Argentina Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.5.6.2. Key Country Dynamics
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Breast Cancer Diagnostics Market, 2018 - 2030 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. Hologic Inc.
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Platform Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Genomic Health (Exact Sciences Corporation)
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Platform Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. BD
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Platform Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Danaher
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Platform Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Koninklijke Philips N.V
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Platform Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. QIAGEN
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Platform Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Thermo Fisher Scientific Inc
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Platform Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Myriad Genetics
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Platform Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Argon Medical Devices, Inc.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Platform Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. F. Hoffmann-La Roche Ltd.
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Platform Benchmarking
      • 9.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Breast Cancer Diagnostics Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Breast Cancer Diagnostics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Breast Cancer Diagnostics Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 North America Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 11 North America Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 12 North America OTC US Breast Cancer Diagnostics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 13 U.S Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 U.S Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 15 U.S Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 17 Canada Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 19 Canada Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 21 Mexico Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Mexico Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Mexico Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 24 Mexico Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 Europe Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 28 Europe Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 29 Europe Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 UK Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 UK Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 33 UK Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 34 Germany Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Germany Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 36 Germany Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 37 Germany Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 38 France Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 France Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 40 France Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 41 France Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 42 Italy Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Italy Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 44 Italy Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 45 Italy Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 46 Spain Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 47 Spain Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 Spain Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 49 Spain Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 50 Norway Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 51 Norway Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 52 Norway Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 53 Norway Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 54 Sweden Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Sweden Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 56 Sweden Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 57 Sweden Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 58 Denmark Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 Denmark Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 Denmark Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 61 Denmark Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 67 Japan Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Japan Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Japan Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 70 Japan Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 71 China Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 China Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 China Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 74 China Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 75 India Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 76 India Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 India Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 78 India Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 79 Australia Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 80 Australia Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 81 Australia Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 82 Australia Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 83 South Korea Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Korea Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 South Korea Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 86 South Korea Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Thailand Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Thailand Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 90 Thailand Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 91 Latin America Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 92 Latin America Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Latin America Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 94 Latin America Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 95 Latin America Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 96 Brazil Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 97 Brazil Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 98 Brazil Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 99 Brazil Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 100 Argentina Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 101 Argentina Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 102 Argentina Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 103 Argentina Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 104 Middle East Africa Breast Cancer Diagnostics Market, by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East Africa Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 106 Middle East Africa Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 107 Middle East Africa Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 108 Middle East Africa Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 109 South Africa Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 110 South Africa Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 South Africa Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 112 South Africa Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 117 UAE Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 118 UAE Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 119 UAE Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 120 UAE Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Breast Cancer Diagnostics Market, by Type, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Breast Cancer Diagnostics Market, by Product, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Breast Cancer Diagnostics Market by Application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Breast Cancer Diagnostics Market by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping, 2024
  • Fig. 15 Global Breast Cancer Diagnostics Market: Type Movement Analysis
  • Fig. 16 Global Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Global Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Global Genomic Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Global Blood Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Global Other Tests Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Global Breast Cancer Diagnostics Market: Product Movement Analysis
  • Fig. 22 Global Platform-Based Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Global Imaging Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Global Biopsy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Global Instrument-Based Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global Microarrays Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Global PCR Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global Next Generation Sequencing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Global Breast Cancer Diagnostics Market: Application Movement Analysis
  • Fig. 31 Global Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global Diagnostic & Predictive Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global Prognostic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Global Research Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Global Breast Cancer Diagnostics Market: End Use Movement Analysis
  • Fig. 36 Global Hospitals & Clinics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Global Medical Labs & Diagnostics Centres Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Regional Marketplace: Key Takeaways
  • Fig. 40 Regional Outlook, 2024 & 2030
  • Fig. 41 Global Breast Cancer Diagnostics Market: Regional Movement Analysis
  • Fig. 42 North America Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East And Africa Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 UAE Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait Breast Cancer Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)